- Integra LifeSciences Holdings press release ( NASDAQ: IART ): Q4 Non-GAAP EPS of $0.94 beats by $0.04 .
- Revenue of $398M (-1.8% Y/Y) misses by $0.57M .
- Outlook: For the full-year 2023, the Company expects revenues to be in a range of $1,602 million to $1,620 million, representing reported growth of approximately 2.9% to 4.0% and organic growth in the range of 4.0% to 5.2% vs consensus of $1.62b. Adjusted earnings per diluted share are expected to be between $3.43 and $3.51 vs consensus of $3.53
For further details see:
Integra LifeSciences Holdings Non-GAAP EPS of $0.94 beats by $0.04, revenue of $398M misses by $0.57M